Some studies suggest that semaglutide could improve insulin sensitivity
However, the genetic associations with l-carnitine and with the outcomes are all from studies in people of European descent, with genomic control
Measurements such as waist circumference or body fat percentage testing may show modest improvements
Where the Science Is Headed Now The next phase of the GLP-1 story is less about format and more about stability in the body over time, a shift that became tangible in December 2025 when the FDA approved Novo Nordisks oral semaglutide (Wegovy), the first daily GLP-1 pill cleared for obesity treatment
Carnitine supplementation has protective and detrimental effects in Saccharomyces cerevisiae that are genetically mediated
For instance, identification of suicidal outcomes by means of ICD codes registered during routine clinical practice databases has been associated with a slight under-registration of cases, which may result in underestimation of the association between drug exposure and SIS outcomes [35], and studies validating suicidal classification have concluded that ICD codes have good positive predictive value but low specificity [36]